Last update:

Oncology & Cancer news

Oncology & Cancer

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

Oncology & Cancer

AI model shows potential for identifying sex-specific risks associated with brain tumors

For years, cancer researchers have noticed that more men than women get a lethal form of brain cancer called glioblastoma. They've also found that these tumors are often more aggressive in men. But pinpointing the characteristics ...

Oncology & Cancer

Study explores novel therapeutic treatment for glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is ...

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Oncology & Cancer

Colonoscopies among the young are on the rise

Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommended.

Oncology & Cancer

How skin cancer virus outcompetes host cell replication

University of Pittsburgh researchers have shown for the first time how Merkel cell polyomavirus (MCV), which causes an aggressive skin cancer called Merkel cell carcinoma, initiates DNA replication in host cells.

Oncology & Cancer

Expert panel updates cancer and aging guidelines

In an effort to improve treatment outcomes and quality of life for older adults with cancer, researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and colleagues ...

Oncology & Cancer

Researchers unravel metabolic regulation in aneuploid tumor cells

A research team led by Prof. Yang Zhenye from the University of Science and Technology of China (USTC) of Chinese Academy of Sciences (CAS), in collaboration with Guo Jing from the First Affiliated Hospital of USTC, has made ...

Oncology & Cancer

What exactly is aspartame and what's the controversy?

An agency of The World Health Organization, The International Agency for Research on Cancer (IARC), has declared that the artificial sweetener aspartame is a possible human carcinogen.